By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on the current article's thesis, highlighting risks such as SpaceX's unproven public-market sustainability, high valuations, regulatory hurdles, and potential market cannibalization of smaller players.
Risk: SpaceX's unproven public-market sustainability and potential market cannibalization of smaller players
Opportunity: None identified
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
SpaceX, the aerospace and AI company founded by Elon Musk, will likely become the largest IPO in history when it goes public on June 12. But at its target valuation of $1.77 trillion, it will be valued at 95 times its 2025 sales. It's also more than four times oversubscribed.
Instead of chasing SpaceX's wild market debut, it's smarter to buy two other stocks that will benefit from the same tailwinds without the stomach-churning volatility: Rocket Lab (NASDAQ: RKLB), which launches reusable orbital rockets like SpaceX, and AST SpaceMobile (NASDAQ: ASTS), which produces Low Earth Orbit (LEO) satellites like SpaceX's Starlink.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Rocket Lab and AST don't directly compete with SpaceX, but they'll benefit from growth in the same markets. Rocket Lab has already launched 88 rockets to date, and it's expanding its business with more orbital and spacecraft manufacturing services. AST, which helps telecom companies cover rural areas with wireless satellite connections, plans to have 45 to 60 satellites in orbit by the end of 2026, and up to 248 satellites within the next few years.
From 2025 to 2028, analysts expect Rocket Lab's revenue to more than double, and for AST's revenue to surge more than 26 times. Both stocks are also arguably cheaper than SpaceX relative to their near-term growth potential, but the same rising tide should lift their boats.
Before you buy stock in Rocket Lab, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Rocket Lab wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $439,038! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,277,804!
Now, it’s worth noting Stock Advisor’s total average return is 942% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
Four leading AI models discuss this article
"A SpaceX IPO at a $1.77T valuation is highly aggressive and unlikely to hold in public markets; RKLB and ASTS offer no free insurance against high capex, growth uncertainty, or rate-driven multiple compression."
The piece treats SpaceX as an almost guaranteed IPO catalyst and markets in Rocket Lab and AST as low-risk hedges. But crucial context is missing: SpaceX’s private financing history raises questions about public-market sustainability, there’s no proven public-track record yet, and Starlink’s revenue profitability may take longer than hype suggests. RKLB and ASTS carry their own capex, regulatory, and government-contract risks, and their growth assumptions hinge on launches and satellite deployments that can disappoint. The “indispensable monopoly” framing reads more marketing than risk-adjusted thesis. Expect elevated volatility and execution risk, not a smooth re-rating of SpaceX on day one.
Strongest counter: public markets rarely reward a rocket company at a 1.77 trillion valuation without demonstrated profitability; even if SpaceX goes public, Starlink economics and regulatory costs could cap upside and trigger a meaningful re-rating.
"The article conflates the potential market tailwinds of the space industry with the operational realities of smaller competitors, ignoring the risk that SpaceX’s scale advantage acts as a barrier to entry rather than a rising tide."
The article's premise of a $1.77 trillion SpaceX IPO on June 12 is factually unsubstantiated and highly speculative, as no such date or valuation has been confirmed by SpaceX. While the 'rising tide' thesis for RKLB and ASTS is theoretically sound, investors must distinguish between SpaceX’s vertical integration—which captures margin across launch, satellite manufacturing, and service—and the niche roles of RKLB and ASTS. RKLB is a legitimate launch provider, but ASTS faces immense capital expenditure hurdles to scale its LEO constellation. Buying these as 'proxies' for SpaceX ignores the risk that SpaceX’s dominance may actually cannibalize the market share of smaller, less-capitalized competitors rather than lifting them.
If the space sector experiences a 'broad-market' re-rating driven by massive government and defense spending, the valuation gap between these smaller players and a hypothetical SpaceX could compress, leading to outsized gains for the smaller, more agile firms.
"RKLB and ASTS are being marketed as 'safer' alternatives to an unconfirmed IPO with a nonsensical valuation, but both face severe execution and cash-burn risks that the article minimizes."
This article conflates speculation with analysis. The June 12 IPO date is unconfirmed—SpaceX hasn't announced one. The 95x sales multiple is absurd for any aerospace company; for context, Lockheed Martin trades ~1.2x sales. The article then pivots to RKLB and ASTS as 'safer' plays, but RKLB has burned cash for years (negative FCF through 2024) and ASTS is pre-revenue with massive execution risk. The 26x revenue growth projection for ASTS assumes perfect satellite deployment and customer adoption—both unproven. The article is essentially a sales funnel for Motley Fool's paid service, not rigorous analysis.
If SpaceX does IPO and the market is genuinely starved for space-sector exposure, a rising tide could lift RKLB and ASTS regardless of fundamentals—momentum and FOMO have driven worse valuations. The satellite broadband TAM is real.
"RKLB and ASTS face steeper competitive and regulatory risks than the article acknowledges, making their growth projections fragile."
The article's pitch for RKLB and ASTS as lower-volatility proxies for SpaceX-driven growth ignores execution and competitive realities. RKLB's 88 launches to date remain modest against SpaceX cadence, while ASTS's plan for 45-60 satellites by end-2026 faces spectrum, regulatory, and capital hurdles that could delay the projected 26x revenue surge. Both trade at premiums reflecting hype rather than proven margins; any SpaceX IPO delay or Starlink capacity expansion would likely pressure smaller LEO players first. The Motley Fool framing also highlights its own paid service, suggesting selective emphasis on upside scenarios.
RKLB and ASTS could still capture niche defense and rural connectivity contracts that SpaceX deprioritizes, allowing the revenue multiples to hold if government spending accelerates through 2028.
"Regulatory/licensing choke points could cap ASTS growth and compress multiples, making the 26x revenue premise speculative."
Responding to Grok: I’d add a regulatory choke point Grok didn’t emphasize. ASTS’s upside hinges on timely spectrum licensing, cross-border approvals, and DoD spectrum use; delays here can stall deployment and keep cash burn high, even if SpaceX cadence remains brisk. That regulatory risk could compress the revenue multiple far more than a SpaceX IPO delay would, making ASTS's 26x revenue premise speculative rather than robust.
"A SpaceX IPO will likely trigger a capital flight from smaller space stocks toward the market leader, causing significant multiple compression for RKLB and ASTS."
Claude, you hit the valuation absurdity, but the real risk isn't just the 95x sales multiple—it's the 'winner-take-all' dynamic in LEO. If SpaceX goes public, they won't just lift the tide; they'll drain the liquidity pool. Institutional capital will rotate into the SpaceX 'blue chip' proxy, leaving RKLB and ASTS to fight for scraps in a high-interest-rate environment. The 'proxy' thesis is a trap; these companies are likely to see multiple compression, not expansion, post-IPO.
"SpaceX IPO could expand sector demand faster than it cannibalizes smaller players, but the article provides zero evidence either way."
Gemini's 'winner-take-all' rotation thesis is sharper than the proxy argument, but it assumes institutional capital is zero-sum. Reality: if a SpaceX IPO expands the sector's total addressable institutional interest—pension funds, space-focused ETFs, defense allocators—RKLB and ASTS could see *both* multiple compression *and* absolute dollar inflows. The question isn't whether SpaceX siphons capital; it's whether the sector pie grows faster than SpaceX's slice. Nobody's quantified that.
"Fresh capital inflows risk funding burn at RKLB and ASTS instead of sustaining multiples."
Claude's sector-pie expansion thesis overlooks how RKLB's ongoing negative FCF and ASTS's pre-revenue burn would absorb fresh defense inflows via dilution rather than multiple support. If 2026 spectrum or launch delays hit first, pension and ETF money could still rotate to SpaceX's scale even as total space AUM grows, leaving the smaller names with higher effective cost of capital.
The panel consensus is bearish on the current article's thesis, highlighting risks such as SpaceX's unproven public-market sustainability, high valuations, regulatory hurdles, and potential market cannibalization of smaller players.
None identified
SpaceX's unproven public-market sustainability and potential market cannibalization of smaller players